Cure SCG

Cure SCG Fighting for our children as we strive to defeat Limb Girdle Muscle Dystrophy with groundbreaking research. Join us in our quest for a cure ๐Ÿ’™

Hope for families living with LGMD ๐Ÿ’šVery encouraging early results from the ATA-200 clinical trial for LGMD R5 (gamma sa...
03/09/2026

Hope for families living with LGMD ๐Ÿ’š

Very encouraging early results from the ATA-200 clinical trial for LGMD R5 (gamma sarcoglycanopathy) were presented during the MDA Clinical and Scientific Conference, bringing renewed hope to families affected by this rare neuromuscular disease.

๐Ÿ”ฌ Key findings include
โ€ข >90% SGCG expression in muscle fibers at 6 months
โ€ข Sustained reductions in CPK and transaminases at 9 months
โ€ข Encouraging functional improvements in ambulatory patients
โ€ข No serious adverse events reported in the four treated children

Progress in rare diseases is the result of a collective effort with patients, families, researchers, and scientists working together toward better treatment options.

For families living with sarcoglycanopathy, every step forward in research brings renewed hope.

For more information, read the full press release
https://urls.fr/eL0ZLn

๐Ÿ’š

This moment means hope ๐Ÿ’šSupporting the ATA-200 clinical program for LGMD 2C reminds us why we keep going. The dosing of ...
03/03/2026

This moment means hope ๐Ÿ’š
Supporting the ATA-200 clinical program for LGMD 2C reminds us why we keep going. The dosing of a fourth patient is more than science; itโ€™s progress for families who have been waiting for answers.

Rare disease progress happens when families, researchers, clinicians, and advocates move forward together. Weโ€™re deeply grateful to everyone helping make this possible.

Time is muscle. Patients canโ€™t wait, and every milestone matters ๐Ÿ’ช
Weโ€™ll keep pushing so more children and families can have hope too.

On behalf of LGMD CAPHelp shape better cardiac care for people living with LGMDWe are launching an international patient...
02/28/2026

On behalf of LGMD CAP
Help shape better cardiac care for people living with LGMD

We are launching an international patient survey to capture the lived experiences of up to 140 individuals across multiple LGMD subtypes. The goal is to better understand real-world experiences related to access to cardiac care, treatment satisfaction, and daily quality of life, and to explore how these experiences differ across countries.

By listening directly to patients and families, this survey aims to identify meaningful patterns and unmet needs that are often missed in clinical settings alone.

The findings will be included in a scientific publication and presented at the ENMC workshop on cardiac care in November 2026. Bringing the patient voice directly into this expert forum will help strengthen clinical communication, inform future patient engagement strategies, and support more patient-centered approaches to care.

The results will also contribute to the development of a dedicated masterclass for cardiologists treating LGMD patients, created in partnership with Treat NMD, to support improved understanding and management of cardiac involvement in LGMD.

Your data is safe and protected.
All responses will be fully anonymized prior to analysis and securely stored by Treat NMD.

If you are living with LGMD or caring for someone who is, we encourage you to share your experience and help shape the future of cardiac care for the LGMD community.

๐Ÿ‘‰ To take the survey; send an email to web@lgmdcab.org

๐Ÿ’š

Rare Disease Day ๐Ÿ’šOur journey with rare disease began only three years ago.Three years of learning a new language we nev...
02/28/2026

Rare Disease Day ๐Ÿ’š

Our journey with rare disease began only three years ago.
Three years of learning a new language we never expected to learn; medical terms, clinical trials, uncertainty, and hope.

In this short time, we advocated. We traveled across countries. We sat in medical conferences that, at first, felt overwhelming and impossible to understand. Slowly, we learned. We asked questions. We kept showing up.

We partnered with researchers and health institutions, working to help move science forward. But the strongest connection we found was not in conference rooms; it was with other parents and children.

We understand each other without explanation.
We feel what others feel.
Our children connect instantly, as if they already know they are not alone.
We hold each other up when the weight becomes too heavy.

Some families have been fighting for decades. Their strength lights the path for families like ours. Their advocacy made space for progress, for research, for hope.

To every parent raising a child with a rare disease: you are the momentum behind change. You are the voice science listens to. You are the reason progress continues.

Today we raise awareness for rare diseases and for Limb-Girdle Muscular Dystrophy (LGMD).
Awareness leads to research.
Research leads to treatments.
And treatments lead to hope.

No family should walk this path alone.
Together, we move forward.
Together, we keep going.
Time is muscle.

Ramadan is a season of mercy, generosity, and hope ๐ŸŒ™๐Ÿ’šFor families living with Limb-Girdle Muscular Dystrophy, hope means...
02/20/2026

Ramadan is a season of mercy, generosity, and hope ๐ŸŒ™๐Ÿ’š

For families living with Limb-Girdle Muscular Dystrophy, hope means research moving forward and treatments that cannot wait.

At CureSCG, every donation helps accelerate gene therapy research and brings us closer to real options for children and families affected by sarcoglycanopathy.

This Ramadan, your support can make a meaningful difference and help ensure patients are not left waiting.

Donate, share, and be part of the progress.
๐Ÿ”— Donation link in bio

It was wonderful to see Joe and Peter from the  and spend time together. We are deeply thankful for their continued hard...
01/29/2026

It was wonderful to see Joe and Peter from the and spend time together. We are deeply thankful for their continued hard work and dedication in advancing the first ever LGMD2C clinical trial, which has brought hope to so many families in our community.

What made this moment especially meaningful was seeing children with the same condition connect with one another. These moments of understanding, belonging, and shared experience matter just as much as the science. They remind us why community is so important for our kids and our families.

As a nonprofit supporting research and patient advocacy, we are grateful to stand alongside those working tirelessly to move LGMD research forward and to build a stronger, more connected community for our children.

Thank you, Dion Foundation, for all that you do. ๐Ÿ’š

As we move into 2026, weโ€™re proud to welcome Sheena Urdaz as a Board Member, Patient Advocate, and Fundraising Lead at C...
01/16/2026

As we move into 2026, weโ€™re proud to welcome Sheena Urdaz as a Board Member, Patient Advocate, and Fundraising Lead at CureSCG.

Sheenaโ€™s connection to our mission is deeply personal. As both a healthcare professional and a parent of children living with LGMD, she brings lived experience, compassion, and a strong voice for families navigating this disease. Her dedication will help strengthen patient advocacy efforts and support our work to accelerate research toward a cure for LGMD sarcoglycanopathies.

We are truly grateful to have passionate, patient-driven leaders like Sheena joining our team. With a growing community and shared purpose, we will continue pushing forward for all families affected by LGMD. ๐Ÿ’š

Learn more about our full team:
https://curescg.org/our-team

Hello 2026 โœจ๐Ÿ’šStepping into this new year with hope, faith, and gratitude for everyone who has supported our journey thro...
01/01/2026

Hello 2026 โœจ๐Ÿ’š
Stepping into this new year with hope, faith, and gratitude for everyone who has supported our journey through CureSCG. 2025 taught us patience, strength, and the power of community, and now we look ahead with open hearts.

May this year bring peace, healing, and breakthroughs for all the families we fight for. Trusting Godโ€™s plan, and believing that 2026 will carry us closer to the future we are working so hard to build. ๐Ÿคโœจ

Hereโ€™s to new beginnings, new strength, and a brighter year for all of us.

12/25/2025

This holiday season, give a gift that lasts beyond Christmas and into the New Year ๐Ÿค

Your support helps drive research and brings us closer to real hope for those living with LGMD.

Thank you for being part of our journey, hereโ€™s to a year filled with progress, strength, and possibility. ๐ŸŽ„โœจ

12/18/2025

Sara draws with a strength you can feel, every line a reminder that creativity moves where muscles sometimes cannot.

Let us tell you why this matters right now.

Because CureSCG is actively raising funds and donations to advance gene therapy research for LGMD 2C and 2D. From community fundraising to direct donations, and through art like Saraโ€™s. These efforts help move research forward toward real treatments and, ultimately, a cure.

Every purchase, every donation, and every shared effort helps power this work. It means research can continue, trials can progress, and families can hold on to real hope for the future.

๐Ÿ–ผ๏ธ Learn more or donate: www.CureSCG.org
๐ŸŽจ Shop Saraโ€™s art: https://curescg.org/shop

With gratitude to the LGMD community today and always. ๐Ÿงก๐Ÿ
11/27/2025

With gratitude to the LGMD community today and always. ๐Ÿงก๐Ÿ

Address

Alpharetta, GA

Alerts

Be the first to know and let us send you an email when Cure SCG posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Cure SCG:

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram